Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

Similar articles for PubMed (Select 10078487)

1.

Effectiveness of influenza vaccine in health care professionals: a randomized trial.

Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC.

JAMA. 1999 Mar 10;281(10):908-13.

PMID:
10078487
2.

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.

Nichol KL, Mendelman PM, Mallon KP, Jackson LA, Gorse GJ, Belshe RB, Glezen WP, Wittes J.

JAMA. 1999 Jul 14;282(2):137-44.

PMID:
10411194
3.

Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.

Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ, Cox NJ, Lilac HA, Hall H, Klimov A, Fukuda K.

JAMA. 2000 Oct 4;284(13):1655-63.

PMID:
11015795
4.
5.

Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial.

Loeb M, Russell ML, Moss L, Fonseca K, Fox J, Earn DJ, Aoki F, Horsman G, Van Caeseele P, Chokani K, Vooght M, Babiuk L, Webby R, Walter SD.

JAMA. 2010 Mar 10;303(10):943-50. doi: 10.1001/jama.2010.250.

PMID:
20215608
6.

Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.

Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, Watts M, Kozinetz C, Hessel C, Glezen WP.

Pediatrics. 2005 Sep;116(3):e397-407.

7.

Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.

Sugaya N, Nerome K, Ishida M, Matsumoto M, Mitamura K, Nirasawa M.

JAMA. 1994 Oct 12;272(14):1122-6.

PMID:
7933325
8.

[Effectiveness of influenza vaccine in health-care workers].

Nishi K, Mizuguchi M, Ueda A.

Kansenshogaku Zasshi. 2001 Oct;75(10):851-5. Japanese.

PMID:
11712359
9.

Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.

Njuguna H, Ahmed J, Oria PA, Arunga G, Williamson J, Kosgey A, Muthoka P, Mott JA, Breiman RF, Katz MA.

Vaccine. 2013 Sep 23;31(41):4662-7. doi: 10.1016/j.vaccine.2013.07.005. Epub 2013 Jul 13.

PMID:
23859843
10.

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.

Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M.

N Engl J Med. 1998 May 14;338(20):1405-12.

11.

The effectiveness of vaccination against influenza in healthy, working adults.

Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M, Magnan S, Drake M.

N Engl J Med. 1995 Oct 5;333(14):889-93.

12.

Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care.

Vesikari T, Fleming DM, Aristegui JF, Vertruyen A, Ashkenazi S, Rappaport R, Skinner J, Saville MK, Gruber WC, Forrest BD; CAIV-T Pediatric Day Care Clinical Trial Network.

Pediatrics. 2006 Dec;118(6):2298-312.

13.

Surveillance for influenza--United States, 1997-98, 1998-99, and 1999-00 seasons.

Brammer TL, Murray EL, Fukuda K, Hall HE, Klimov A, Cox NJ.

MMWR Surveill Summ. 2002 Oct 25;51(7):1-10.

14.

Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial.

Treanor JJ, Schiff GM, Hayden FG, Brady RC, Hay CM, Meyer AL, Holden-Wiltse J, Liang H, Gilbert A, Cox M.

JAMA. 2007 Apr 11;297(14):1577-82.

PMID:
17426277
15.

Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age.

Allsup S, Gosney M, Haycox A, Regan M.

Health Technol Assess. 2003;7(24):iii-x, 1-65.

16.

Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination.

Gorse GJ, O'connor TZ, Young SL, Habib MP, Wittes J, Neuzil KM, Nichol KL.

Chest. 2006 Oct;130(4):1109-16.

PMID:
17035445
17.

Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study.

Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S.

Chest. 2004 Jun;125(6):2011-20.

PMID:
15189916
18.

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, King J, Kotloff K, Bernstein DI, Hayden FG, Zangwill K, Yan L, Wolff M.

J Pediatr. 2000 Feb;136(2):168-75.

PMID:
10657821
19.

Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial.

Hoberman A, Greenberg DP, Paradise JL, Rockette HE, Lave JR, Kearney DH, Colborn DK, Kurs-Lasky M, Haralam MA, Byers CJ, Zoffel LM, Fabian IA, Bernard BS, Kerr JD.

JAMA. 2003 Sep 24;290(12):1608-16.

PMID:
14506120
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk